SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $282,000 | +23.1% | 2,554 | -16.4% | 0.02% | +26.3% |
| Q2 2022 | $229,000 | -3.8% | 3,054 | +0.3% | 0.02% | +11.8% |
| Q1 2022 | $238,000 | -13.1% | 3,044 | -0.1% | 0.02% | -15.0% |
| Q4 2021 | $274,000 | -2.5% | 3,047 | +0.1% | 0.02% | -16.7% |
| Q3 2021 | $281,000 | +23.2% | 3,043 | +3.9% | 0.02% | +20.0% |
| Q2 2021 | $228,000 | +5.1% | 2,928 | +0.3% | 0.02% | -9.1% |
| Q1 2021 | $217,000 | -49.3% | 2,918 | +16.3% | 0.02% | -56.0% |
| Q4 2020 | $428,000 | +21.6% | 2,509 | +0.2% | 0.05% | +2.0% |
| Q3 2020 | $352,000 | -40.6% | 2,505 | -32.3% | 0.05% | -47.9% |
| Q2 2020 | $593,000 | +47.5% | 3,700 | 0.0% | 0.09% | +25.3% |
| Q1 2020 | $402,000 | -54.8% | 3,700 | -32.8% | 0.08% | -65.8% |
| Q3 2018 | $889,000 | +215.2% | 5,503 | +115.5% | 0.22% | +812.5% |
| Q3 2011 | $282,000 | – | 2,554 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |